PKC NVR (Rydapt 25 mg)
Generic Name: midostaurin
Pill with imprint PKC NVR is Orange, Capsule-shape and has been identified as Rydapt 25 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Rydapt is used in the treatment of systemic mastocytosis; acute myeloid leukemia and belongs to the drug class multikinase inhibitors. Rydapt 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for PKC NVR
Rydapt
- Generic Name:
- midostaurin
- Imprint:
- PKC NVR
- Strength:
- 25 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC):
- 00078-0698
More about Rydapt (midostaurin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
